Mic Capital Management Uk LLP Recursion Pharmaceuticals, Inc. Transaction History
Mic Capital Management Uk LLP
- $363 Million
- Q1 2025
A detailed history of Mic Capital Management Uk LLP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mic Capital Management Uk LLP holds 9,644,032 shares of RXRX stock, worth $53.9 Million. This represents 14.06% of its overall portfolio holdings.
Number of Shares
9,644,032
Previous 9,644,033
-0.0%
Holding current value
$53.9 Million
Previous $65.2 Million
21.75%
% of portfolio
14.06%
Previous 9.89%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
363Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$195 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$180 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$136 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$96.8 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$82 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.01B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...